Evaluation Of Clinical Effectiveness Of Pathogenetically Oriented Therapy For Cervical Intraepithelial Neoplasia
DOI:
https://doi.org/10.47750/pnr.2022.13.S09.317Abstract
Despite the widespread introduction of preventive measures, the development and implementation of new methods for the early diagnosis and treatment of cervical intraepithelial neoplasia is relevant. The average total effectiveness of the developed personalized therapy exceeds the traditional one by more than ≥51.8%. A comparative analysis of long-term results of treatment has convincingly demonstrated a higher clinical efficacy of pathogenetically substantiated therapy.
Downloads
Published
2022-11-25 — Updated on 2022-11-25
Versions
- 2022-11-25 (2)
- 2022-11-25 (1)
Issue
Section
Articles
How to Cite
Evaluation Of Clinical Effectiveness Of Pathogenetically Oriented Therapy For Cervical Intraepithelial Neoplasia. (2022). Journal of Pharmaceutical Negative Results, 2665-2668. https://doi.org/10.47750/pnr.2022.13.S09.317